Suppr超能文献

2022 - 2023年拉脱维亚流感病毒、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)、呼吸道合胞病毒、鼻病毒、腺病毒、博卡病毒及其他呼吸道病毒的流行情况与共同检测

Circulation and Codetections of Influenza Virus, SARS-CoV-2, Respiratory Syncytial Virus, Rhinovirus, Adenovirus, Bocavirus, and Other Respiratory Viruses During 2022-2023 Season in Latvia.

作者信息

Kampenusa Inara, Niedre-Otomere Baiba, Trofimova Julija, Pole Ilva, Pakarna Gatis, Savicka Oksana, Nikisins Sergejs

机构信息

National Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases" Laboratory Service, Riga East University Hospital, Linezera Street 3, LV-1006 Riga, Latvia.

Department of Infectology, Riga Stradins University, Riga East University Hospital, Linezera Street 3, LV-1006 Riga, Latvia.

出版信息

Viruses. 2024 Oct 22;16(11):1650. doi: 10.3390/v16111650.

Abstract

This retrospective study analysed the routine data obtained by multiplex real-time RT-qPCR methods for respiratory virus detection. A total of 4814 respiratory specimens collected during 1 September 2022-31 August 2023 were included in the study. A total of 38% of the specimens were positive for at least one target, with the incidence maximum (82%) for the small children (age group 0-4 years). The five dominant virus groups were rhinovirus (RV, 12%), influenza virus A (IAV, 7%), adenovirus (AdV, 6%), respiratory syncytial virus (RSV, 5%), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, 5%). The specimens with multi-detections represented 19% of the positives, unevenly distributed (n = 225, 56, 43, 24) among the age groups 0-4, 5-14, 15-64, and 65< years, respectively. The dominant virus groups in multi-positive specimens were RV (53%), AdV (43%), and bocavirus (BoV, 35%)-in mutual pairs as well as all three together-followed by RSV (21%), and IAV (15%). Our study focused on the specimens with codetections and provides an insight into the variety of the respiratory virus interactions in Latvia during the first year since pandemic-related social restriction measures were eased. The observations also emphasise the need to consider the differentiation between rhinoviruses and enteroviruses, especially for the youngest patients in the age group 0-4.

摘要

这项回顾性研究分析了通过多重实时逆转录定量聚合酶链反应方法获得的用于呼吸道病毒检测的常规数据。该研究纳入了2022年9月1日至2023年8月31日期间收集的总共4814份呼吸道标本。总共38%的标本至少对一种靶标呈阳性,其中幼儿(0 - 4岁年龄组)的阳性率最高(82%)。五个主要病毒组为鼻病毒(RV,12%)、甲型流感病毒(IAV,7%)、腺病毒(AdV,6%)、呼吸道合胞病毒(RSV,5%)和严重急性呼吸综合征冠状病毒2(SARS-CoV-2,5%)。多重检测的标本占阳性标本的19%,在0 - 4岁、5 - 14岁、15 - 64岁和65岁以上年龄组中分布不均(分别为n = 225、56、43、24)。多重阳性标本中的主要病毒组为RV(53%)、AdV(43%)和博卡病毒(BoV,35%)——相互配对以及三者同时出现——其次是RSV(21%)和IAV(15%)。我们的研究聚焦于多重检测的标本,并深入了解了自与大流行相关的社会限制措施放宽后的第一年拉脱维亚呼吸道病毒相互作用的多样性。这些观察结果还强调了需要考虑鼻病毒和肠道病毒之间的区别,特别是对于0 - 4岁年龄组中最年幼的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff10/11598885/bb646279005a/viruses-16-01650-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验